Completed PHASE1 INTERVENTIONAL 3-arm NCT01047280

Use of Conjugated Linoleic Acid as a Nutraceutical for Weight Loss in Humans (CLA)

Sponsor: University of Manitoba

Conditions Body Composition Body Weight Hyperlipidemia Inflammation Oxidative Stress

Interventions Clarinol G-80 ® treatment G-c9, t11 Safflower oil

Updated 5 times since 2017 Last updated: Jan 11, 2010 Started: Nov 30, 2006 Primary completion: Mar 31, 2008 Completion: May 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Body Composition and Body Weight, this trial is completed. The trial is conducted by University of Manitoba and has accumulated 5 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Nov 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Manitoba

Data source: University of Manitoba

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.